NOVONIX Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

NOVONIX şirketinin toplam hissedar öz sermayesi $158.1M ve toplam borcu $64.6M olup, bu da borç-öz sermaye oranını 40.9% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $240.8M ve $82.8M dir.

Anahtar bilgiler

40.9%

Borç/özkaynak oranı

US$64.59m

Borç

Faiz karşılama oranı	n/a
Nakit	US$47.13m
Eşitlik	US$158.07m
Toplam yükümlülükler	US$82.77m
Toplam varlıklar	US$240.84m

Son finansal sağlık güncellemeleri

Recent updates

We Think NOVONIX (ASX:NVX) Has A Fair Chunk Of Debt

Sep 26

Health Check: How Prudently Does NOVONIX (ASX:NVX) Use Debt?

Jun 01

Shareholders Will Probably Hold Off On Increasing NOVONIX Limited's (ASX:NVX) CEO Compensation For The Time Being

Apr 10

Is NOVONIX (ASX:NVX) Weighed On By Its Debt Load?

Mar 01

Is NOVONIX (ASX:NVX) Using Debt In A Risky Way?

Oct 05

Is Novonix (ASX:NVX) Using Debt Sensibly?

May 25

Is Novonix (ASX:NVX) Using Too Much Debt?

Sep 04

Is Novonix (ASX:NVX) Using Too Much Debt?

Jun 02

Who Has Been Buying Novonix Limited (ASX:NVX) Shares?

Mar 01

Could The Novonix Limited (ASX:NVX) Ownership Structure Tell Us Something Useful?

Jan 25

Does Novonix (ASX:NVX) Have A Healthy Balance Sheet?

Dec 21

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: NVX 'nin kısa vadeli varlıkları ( $57.9M ) kısa vadeli yükümlülüklerini ( $9.4M ) aşıyor.

Uzun Vadeli Yükümlülükler: NVX 'un kısa vadeli varlıkları ( $57.9M ) uzun vadeli yükümlülüklerini ( $73.4M ) karşılamamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: NVX 'nin net borç/öz sermaye oranı ( 11% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: NVX 'nin borç/öz sermaye oranı son 5 yılda 108.8% seviyesinden 40.9% seviyesine düştü.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: NVX şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: NVX un, serbest nakit akışı her yıl % 40.4 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

NOVONIX Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 3/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

We Think NOVONIX (ASX:NVX) Has A Fair Chunk Of Debt

Health Check: How Prudently Does NOVONIX (ASX:NVX) Use Debt?

Is NOVONIX (ASX:NVX) Weighed On By Its Debt Load?

Is NOVONIX (ASX:NVX) Using Debt In A Risky Way?

Is Novonix (ASX:NVX) Using Debt Sensibly?

Is Novonix (ASX:NVX) Using Too Much Debt?

Recent updates

NOVONIX Limited to Report Q3, 2024 Results on Oct 30, 2024

We Think NOVONIX (ASX:NVX) Has A Fair Chunk Of Debt

Director recently sold AU$93k worth of stock

First half 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

NOVONIX Limited Announces Board Changes

Health Check: How Prudently Does NOVONIX (ASX:NVX) Use Debt?

NOVONIX Limited Announces Resignation of Nick Liveris as Chief Financial Officer

Price target decreased by 9.1% to AU$1.00

Shareholders Will Probably Hold Off On Increasing NOVONIX Limited's (ASX:NVX) CEO Compensation For The Time Being

New minor risk - Share price stability

Axon Graphite Limited signed a definitive agreement to acquire Md South Tenements Pty. Ltd. from NOVONIX Limited (ASX:NVX) for approximately AUD 10 million on April 3, 2024.

NOVONIX Limited, Annual General Meeting, Apr 17, 2024

Is NOVONIX (ASX:NVX) Weighed On By Its Debt Load?

Full year 2023 earnings: EPS and revenues exceed analyst expectations

NOVONIX Limited Appoints Sharan Burrow AC to Its Board of Directors, Effective 28 February, 2024

NOVONIX Limited to Report Q4, 2023 Results on Jan 30, 2024

Daniel Akerson Resigns from NOVONIX Limited Board of Directors

New major risk - Revenue and earnings growth

NOVONIX Limited to Report Q3, 2023 Results on Oct 26, 2023

New major risk - Share price stability

Is NOVONIX (ASX:NVX) Using Debt In A Risky Way?

Non-Executive Chairman recently bought AU$296k worth of stock

Novonix Limited Provide an Update on Production from Its Proprietary, Continuous Induction Generation 3 Furnaces

Novonix Limited Announces the Cessation of Zhanna Golodryga as Director

Novonix Limited Announces Board Changes

Non-Executive Chairman exercised options to buy AU$534k worth of stock.

First half 2023 earnings released: US$0.058 loss per share (vs US$0.064 loss in 1H 2022)

Novonix Limited's Battery Technology Solutions Division Commissions Zero-Waste Cathode Pilot Line

Non-Executive Chairman recently sold AU$356k worth of stock

Novonix Limited announced that it expects to receive AUD 45.05 million in funding from LG Energy Solution, Ltd.

Is Novonix (ASX:NVX) Using Debt Sensibly?

Forecast to breakeven in 2024

First half 2023 earnings released: US$0.057 loss per share (vs US$0.047 loss in 1H 2022)

Price target increased to AU$3.11

Less than half of directors are independent

Less than half of directors are independent

Novonix Limited Announces Board Appointments

Forecast to breakeven in 2024

Price target increased to AU$3.11

Consensus forecasts updated

Is Novonix (ASX:NVX) Using Too Much Debt?

Novonix Limited, Annual General Meeting, Oct 26, 2022

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Novonix Limited, Annual General Meeting, Oct 26, 2022

Independent Non-Executive Director exercised options to buy AU$162k worth of stock.

Consensus forecasts updated

No longer forecast to breakeven

Is Novonix (ASX:NVX) Using Too Much Debt?

Novonix Limited Announces Board Changes

Consensus forecasts updated

NOVONIX Limited Announces Appointment of Jean Oelwang to Board of Directors

Price target decreased to AU$7.44

First half 2022 earnings: EPS and revenues miss analyst expectations

Consensus forecasts updated

Price target decreased to AU$6.97

Consensus forecasts updated

NOVONIX Limited Announces Preliminary Results of Environmental Impact Study

Non-Executive Director Gregory Baynton has left the company

Full year 2021 earnings released: AU$0.049 loss per share (vs AU$0.15 loss in FY 2020)

Price target increased to AU$3.62

Novonix Limited announced that it expects to receive $150 million in funding from Phillips 66

Independent Non-Executive Director exercised options to buy AU$5.6m worth of stock.

First half 2021 earnings released: AU$0.031 loss per share (vs AU$0.055 loss in 1H 2020)

Who Has Been Buying Novonix Limited (ASX:NVX) Shares?

Novonix Limited has completed a Follow-on Equity Offering in the amount of AUD 115.13 million.

Could The Novonix Limited (ASX:NVX) Ownership Structure Tell Us Something Useful?

Price target raised to AU$2.37

Novonix Names Jeff Dahn as Chief Scientific Advisor, Effective July 1, 2021

New 90-day high: AU$1.42